AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00737646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinic-focused intervention
Description: The clinic-focused intervention consists of CRC screening training sessions for clinicians and clinical staff. The provider training sessions will include the presentation of CRC screening statistics and information, and will be heavily interactive and skills-based. The provider training sessions will also focus on the provision of tools for improving clinical staff- and clinician-patient interactions about CRC screening and for office system changes/improvements to identify eligible patients and to track screening.
Study NCT00737646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinic- and patient-focused
Description: This arm will combine the clinic-focused intervention and the patient-focused intervention. The clinic-focused intervention consists of CRC screening training sessions for clinicians and clinical staff as described in Arm 2. The patient-focused intervention includes sending a CRC screening education packet (CDC-developed educational text tailored for use within the study sites), accompanied by a letter from the patient's physician, to patients meeting study inclusion criteria.
Study NCT01917383 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trabodenoson
Description: Ophthalmic eye drop
Study NCT01917383 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost
Description: Ophthalmic eye drop
Study NCT01917383 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Latanoprost
Description: Ophthalmic eye drop
Study NCT01917383 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Timolol
Description: Ophthalmic eye drop
Study NCT02888106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Myrcludex B
Description: Lyophilised powder for solution for subcutaneous injection
Study NCT02888106 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PEG IFN alfa-2a
Description: solution for subcutaneous injection, once per week
Study NCT02888106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEG IFN alfa-2a
Description: solution for subcutaneous injection, once per week
Study NCT02888106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir
Description: Film-coated tablets, 300 mg, per os, once daily
Study NCT04618146 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine Sulfate
Description: intrathecal low dose morphine for early return to normal activity without opioid related complications.
Study NCT04618146 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bupivacaine Hydrochloride
Description: intrathecal bupivacaine 0.5%
Study NCT04618146 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride
Description: intrathecal bupivacaine 0.5%
Study NCT02306681 — intervention group
Intervention type: OTHER
Intervention: No treatment given
Description: This study comprises of a two-part SAQ (Self-Assessment Questionnaire). Paired responses to SAQ1 and SAQ2 will be used to estimate the differences in the frequency of hypoglycaemic episodes between the retrospective and prospective periods.
Study NCT04077021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCW702
Description: Investigational immunotherapy for prostate cancer
Study NCT03744104 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Trivalent influenza vaccine B
Description: 0.5 mL, intramuscular, one dose
Study NCT02282852 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wireless Capsule Endoscopy
Study NCT02282852 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetically steerable capsule endoscopy
Study NCT04976985 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Therapy (OMT)
Description: Osteopathic Manipulative Therapy (OMT) is a non-pharmacological, noninvasive form of manual medicine. Osteopathic physicians receive special training in the musculoskeletal system to detect somatic dysfunction. Osteopathic physicians then move a patient's muscles and joints using techniques that include stretching, gentle pressure and resistance to improve muscle tonicity, treat structural abnormalities, relieve joint restriction, and decrease activation of the pain proprioception pathway.~OMT Standardized Protocol A:~1. Occipital- Alanto release~2. Muscle energy and soft tissue to mid trapezius muscle~3. Muscle energy to cervical spine in all three planes of flexion/extension, rotation and side bending~4. Screening for tender points of C2-C6 at transverse and spinous processes and treatment with counterstain if tender point identified~5. Soft tissue to cervical paraspinal muscles~6. Myo-fascial release of frontal forehead~7. CV4 cranial technique
Study NCT04976985 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care
Description: Receiving standard of care for migraine headaches with pharmacological medications, with no more than two prophylactic medications during the study period. Participants may also take abortive migraine medications.
Study NCT03191617 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Human milk fortifier
Description: Fortification of breastmilk with liquid human milk fortifier in premature infants
Study NCT03191617 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Human milk fortifier
Description: Fortification of breastmilk with liquid human milk fortifier in premature infants
Study NCT00900978 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 7 valent pneumococcal conjugate vaccine (7v-PCV) - Prevenar
Description: The 7v-PCV will be given to children below 2 years of age. Nasopharyngeal swabs will be taken from the children before vaccination and after finishing the vaccination. The vaccine will be given in a 2+1 scheme.
Study NCT02478008 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CardiAQ TMVI System (Transapical DS)
Study NCT00049023 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-tyr3-OCTREOTIDE
Study NCT02153268 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Arm - Liposuction procedure and BonoFill transplantation will be done for all subjects on study
Description: Liposuction - will be performed on Visit 2, BonoFill will be based on subject's autologous Human Adipose Tissue Derived Cells (HATDCs).~BonoFill Transplantation will be performed on Visit 6. BonoFill will be administrated to the subject in a single session at one tested cell dose.
Study NCT05405010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stair climbing and descending for 1 minute
Description: Stair climbing and descending for 1 minute
Study NCT05405010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stair climbing and descending for 3 minutes
Description: Stair climbing and descending for 3 minutes
Study NCT05405010 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Seated control
Description: Seated control
Study NCT03527849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction
Description: The intervention will be an MBSR course.
Study NCT04569643 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Actigraphy
Description: Participants will undergo overnight leg actigraphy at baseline. Leg movements will be recorded bilaterally by actigraphic method with two ankle-worn recorders.
Study NCT04569643 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiorespiratory monitoring
Description: All participants will be scanned for presence of sleep-related breathing disorders with a portable monitoring device at baseline. The compact screening device will be attached to the patient's wrist during the night sleep.
Study NCT03527849 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Enhancement Program
Description: Propose to use an active control training, the Health Enhancement Program (HEP), an intervention designed to isolate mindfulness as a testable active ingredient. HEP and MBSR are structurally equivalent in that they share the same amount of in- and out-of class work time. The content of the HEP intervention meet the following criteria: (1) class activities match MBSR activities as closely as possible, (2) activities represent valid, active, therapeutic ingredients in their own right, and (3) these ingredients do not include mindfulness.
Study NCT04400357 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic pancreaticoduodenectomy
Description: Patients in this arm will undergo a pancreaticoduodenectomy with robotic-assisted techonology.
Study NCT04400357 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open pancreaticoduodenectomy
Description: Patients in this arm will undergo an open pancreaticoduodenectomy which is the standard surgical approach.
Study NCT04569643 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuroimaging
Description: All subjects will undergo brain MRI scanning at baseline and in 1-year follow-up. The imaging protocol will include axial T1, T2, T2\*, FLAIR and diffusion-weighted imaging scans that will be made on a 3-Tesla scanner.
Study NCT04569643 — intervention group
Intervention type: OTHER
Intervention: Assessment of cognitive function
Description: Assessment will take place at weeks 0 (baseline) and 52 (1 year follow-up). The neuropsychological protocol will be consist of Montreal Cognitive Assessment (MoCA), 12-word Verbal Memory Test, Benton Visual Retention Test, Frontal Assessment Battery, Trail Making Test (parts A and B), phonetic (as a part of the MoCA) and semantic verbal fluency assessment, Symbol Digit Modalities Test.
Study NCT03111875 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: aggressive warming
Description: Patients will be pre-warming 30 minutes before induction of anesthesia and aggressively warmed during surgery to a target intraoperative core temperature between 37 and 37.5°C.
Study NCT03111875 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: routine thermal management
Description: A forced-air cover will be positioned but will not initially be activated. The warmer will be activated when core temperature decrease to 35.5°C.
Study NCT03717688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entresto
Description: Single dose administration of Entrestro 194 mg sacubitril / 206 mg valstartan
Study NCT03717688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sitagliptin 100mg
Description: 2 x 100mg sitagliptin as single dose.
Study NCT03717688 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: No treatment
Study NCT03855696 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MG1113
Description: MG1113
Study NCT03855696 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of MG1113
Description: Placebo of MG1113
Study NCT01301807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Given IV
Study NCT01301807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panobinostat
Description: Given PO
Study NCT01145742 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: home health/primary care collaboration
Description: self-management support and telemonitoring of BP and blood glucose
Study NCT00799201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxone and Docusate
Description: Naloxone 6mg (15 mL) every 6 hours plus docusate sodium liquid 10 mL (100mg) every 12 hours
Study NCT00896714 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed loop anesthesia
Description: Propofol and Remifentanil are administered automatically using a closed-loop system
Study NCT02774759 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Accelerometer
Description: Participant wears an accelerometer for 7 days before baseline visit to record activity levels, and again before their 6 month visit.
Study NCT04569643 — intervention group
Intervention type: OTHER
Intervention: Sleep quality and mood questionnaires
Description: Self-reporting scales and questionnaires will be used at baseline to assess sleep quality, daytime functioning and mood. The protocol includes the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, the Geriatric Depression Scale.
Study NCT00536302 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Collagen Hydrolysate
Description: Collagen Hydrolysate solution 10 grams per day by mouth for 48 weeks
Study NCT00536302 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo solution per day by mouth for 48 weeks.
Study NCT01648686 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Dental extraction
Description: 3 dental radiographies realised immediately, then 30 days, then 90 days after dental extraction
Study NCT01648686 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental extraction
Description: 3 dental radiographies realised immediately, then 30 days, then 90 days after dental extraction
Study NCT01337583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dapivirine
Description: Vaginal ring containing 25mg dapivirine; one ring inserted every 28 days for at least 15 months
Study NCT01337583 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vaginal Ring containing no drug substance
Study NCT02774759 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Accelerometer
Description: Participant wears an accelerometer for 7 days before baseline visit to record activity levels, and again before their 6 month visit.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires completed at baseline regarding quality of life and diet.~Questionnaires completed at 3 and 6 months regarding quality of life, diet, physical activity, etc.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires
Description: Questionnaires completed at baseline regarding quality of life and diet.~Questionnaires completed at 3 and 6 months regarding quality of life, diet, physical activity, etc.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fitness Test
Description: Fitness test given covering various physical activities at baseline and at 6 month visit.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Fitness Test
Description: Fitness test given covering various physical activities at baseline and at 6 month visit.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance Training
Description: Physical activity guidelines workbook distributed along with activity monitor. Participants receive resistance bands to perform resistance exercises. Exercise handouts and an iPad mini with training videos used to video chat with a research team member. Information from wireless scale and Fitbit sent to Fitbit website to monitor levels.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Participants placed into an exercise plan focused on physical activity only. Physical activity guidelines workbook distributed along with activity monitor.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone Coaching/Phone Calls
Description: Participants called 4 times during the first month, 2 times during the second month, and 1 time per month for the rest of the study. Participants also receive a follow-up call at the end of the study.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Telephone Coaching/Phone Calls
Description: Participants called 4 times during the first month, 2 times during the second month, and 1 time per month for the rest of the study. Participants also receive a follow-up call at the end of the study.
Study NCT02774759 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Chat Sessions
Description: Video chatting between the research team and participants occurs 2 times per month during the first and third months, when new exercises are introduced. Video chatting offered monthly as needed by participants during months 2, 4, 5, and 6.
Study NCT03920345 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MultiZYTE
Description: Subjects can be treated either unilateral or bilateral, depending on their condition and the recommended treatment by the surgeon. The decision is a clinical one and is not influenced by the decision of whether to be included in the study or the subsequent outcomes and QoL analysis.
Study NCT02559622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Secukinumab
Description: 300 mg secukinumab
Study NCT02559622 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Placebo followed by 300 mg secukinumab
Study NCT02559622 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Placebo followed by 150 mg secukinumab
Study NCT02559622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Secukinumab
Description: 150 mg secukinumab
Study NCT03678207 — intervention group
Intervention type: OTHER
Intervention: Anesthesiologist phone call
Description: Patients receiving ambulatory surgery with no prior diagnosis of hypertension but have elevated blood pressure prior to surgery. Patients will receive a phone call from a participating anesthesiologist 1-3 days after surgery notifying them of their high blood pressure and obtaining oral consent to participate in the study. Patients will receive reminders via mail about following up with their PCP.
Study NCT01338441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythromycin
Description: 4mg/Kg, IV during 20 min once
Study NCT01338441 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 4mg/Kg, IV during 20 min once
Study NCT01069432 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: No Intervention
Study NCT01416818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xiaoyao Pill
Description: herb extracts,were received two times a day for 12 weeks without dose changing.
Study NCT01416818 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupleurum+Ginkgo
Description: herb extracts, were received two times a day for 12 weeks without dose changing.
Study NCT01416818 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: The placebo looked like herb extracts and were also received two times a day for 12 weeks without dose changing.
Study NCT04256694 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Rapid Antigen Test for Group A Streptococcus
Description: Rapid strep tests will be performed by throat swab of healthy adult volunteers.
Study NCT03576508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CNTX-4975-05
Description: 1 mg (2mL) IA injection
Study NCT03576508 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Qutenza
Description: 8% topical patch
Study NCT03576508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine (without epinephrine)
Description: 15 mL IA injection of 2% lidocaine (without epinephrine)
Study NCT01337583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapivirine
Study NCT03883256 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: high flow nasal cannula
Description: High flow nasal cannula is a device that delivered heated and humidified high flow gases to at or near body temperature to avoid drying and possible injury to the nasal mucosa. In this study, subjects perform a constant-load exercise test with high flow nasal cannula.
Study NCT03883256 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: nasal cannula
Description: Nasal cannula is a device that delivered oxygen to patients. In this study, subjects perform a constant-load exercise test with nasal cannula.
Study NCT02521506 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Verio Pattern Alert® activated
Study NCT02521506 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Verio Pattern Alert® deactivated
Study NCT02854085 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Art Therapy
Description: The Art Therapy will consist of creating art pieces, narrating thoughts and inner experiences in relation to the pieces produced (2 sessions a month) and guided visits to the art gallery (one session a month) and art museum (one session a month); there will be 12 sessions weekly for 12 weeks. For the next 6 months, sessions will be fortnightly and consist of creating an art piece once a month alternating with a visit to either the art museum or gallery, once a month; there will be 12 sessions in 6 months. Each session will last 45 minutes and will begin with 5 minutes of mindful relaxation to help participants focus on the task ahead.
Study NCT02854085 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Reminiscence Activity
Description: Music Reminiscence activity will be held weekly for 12 weeks and fortnightly for 6 months. Each session will last 45 minutes and will begin with 5 minutes of mindful relaxation to help participants focus on the task ahead. Session will entail listening and watching music videos and discussing activities, events and experiences related to the music; additional prompts such as photographs may be used to facilitate therapy.
Study NCT01434277 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eye Drops with Experimental Preservative
Description: Glycerin, Hypromellose, Polyethylene glycol 400 with experimental preservative PQ-42
Study NCT00112736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib
Description: Given orally